A Multicenter, Randomized, Double-Blind Study to Evaluate Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Crohn's Disease and Evidence of Mucosal Ulceration Save

Date Added
March 24th, 2015
PRO Number
Pro00042714
Researcher
Nilesh Lodhia

Silhouette
Keywords
Crohn's Disease
Summary

The purpose of this study is to evaluate the effectiveness and safety of higher induction and maintenance dosing regimens in subjects with moderately to severely active Crohn's disease.

Institution
MUSC
Recruitment Contact
Jamila Keith
(843) 876-7233
KeithJa@MUSC.edu

Change_preferences

-- OR --

Create_login